Menu
Heru Genomics brings people together by focusing on a highly efficient network, using their capabilities to leverage the power of genomics across their enterprise, creating strategic value, fueling future growth, and refining humanity.
Belief in the power of genetics to change the world drives Heru Genomics to create detailed genetic profiles and offer genetic counseling for reproduction. The focus is on identifying children with high potential and developing skills related to cerebral development, connecting them to form an elite community and collaborating with institutions and organizations.
A major initial step includes the creation of the Heru Biotechnology Research Center in Lima, Peru, and Buenos Aires, Argentina. This cutting-edge research center serves as the core of biotechnology and genetics efforts, spearheading innovative projects.
Heru Genomics harnesses genetics to fundamentally enhance and elevate human capabilities. Deep exploration into genetic makeup aims to understand and optimize traits that contribute to exceptional cognitive and physical performance. The research strategy encompasses:
Extensive genomic data from both contemporary and ancient DNA samples provide a broad and detailed spectrum, aiding in the understanding of human trait evolution and potential.
State-of-the-art techniques, including GWAS and advanced machine learning algorithms, focus on discovering genetic variations to enhance human health, performance, and potential, aiming to unlock extraordinary human capabilities.
Refining polygenic scoring methods allows for the prediction and enhancement of traits leading to improved health, intelligence, and physical abilities, facilitating personal genetic enhancement plans that are ethical and optimized for human potential.
The introduction of BloodLine, a pioneering AI-based platform, guides individuals based on their unique genetic traits. This software facilitates finding compatible partners for personal and professional engagements and supports community-building by analyzing and matching individuals with complementary genetic profiles.
Heru Genomics integrates sophisticated reproductive technologies with advanced genetic analysis to maximize the potential of future generations:
The process begins with the administration of hormones to stimulate the ovaries and increase the number of eggs produced. Once the ovarian follicles reach the desired size, a minor surgical procedure called follicular puncture is performed under anesthesia to extract the oocytes.
The oocytes are then fertilized in the laboratory using advanced techniques. The fertilized eggs (now embryos) are cultured in an incubator, and their development is closely monitored.
On the third or fifth day, when the embryos have reached the blastocyst stage, a few cells are safely removed from each embryo for genetic analysis. BloodLine software analyzes these cells to evaluate each embryo’s genetic makeup.
Based on the comprehensive genetic profile provided by BloodLine, the best embryo(s) are selected for transfer.
The selected embryo is then transferred back to the uterus in a non-surgical procedure that involves placing the embryo into the uterine cavity via a thin catheter inserted through the cervix.
Heru Genomics invites researchers, investors, and organizations to advance the study and application of human genetics. Together, we can transform preventive health and genetic optimization for future generations.
Heru Genomics adheres to the highest ethical standards in all its operations. An ethical oversight committee ensures that all procedures, from oocyte extraction to embryo selection and implantation, are performed with informed consent and in compliance with international ethical and legal standards.
